ASX
Paradigm Biopharmaceuticals
PAR:ASX•Healthcare
Sensitive ASX Announcement
Phase 3 Knee OA Trial Recruiting and Dosing in AUS & US
Published: 30/09/25, 10:46am (AEST)•3 pages